Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 4:00 AM ET

Date/Time Source News Release
06/03/2025 07:30 AM EDT GlobeNewswire Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
05/28/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
05/09/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
05/08/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy
05/07/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
04/01/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine (CT1812) on Alzheimer's Disease Processes
03/25/2025 07:30 AM EDT GlobeNewswire Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer's Disease in Podium Presentation at AD/PD 2025
03/20/2025 07:00 AM EDT GlobeNewswire Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
03/14/2025 08:35 AM EDT GlobeNewswire Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
03/13/2025 04:05 PM EDT GlobeNewswire Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results
Page

Additional News

As of June 11, 2025 • 4:00 AM ET

Date/Time Source News Release
05/08/2025 11:33 AM EDT SeekingAlpha Cognition Therapeutics GAAP EPS of -$0.14 misses by $0.04
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cognition Therapeutics Inc.
03/25/2025 10:00 AM EDT Baystreet Cognition to Reveal Biomarker Findings Next Week
03/20/2025 01:15 PM EDT SeekingAlpha Cognition Therapeutics, Inc (CGTX) Q4 2024 Earnings Call Transcript
03/20/2025 07:48 AM EDT SeekingAlpha Cognition Therapeutics GAAP EPS of -$0.86
03/20/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 20th, 2025
03/20/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cognition Therapeutics Inc.
12/18/2024 09:57 AM EST 24/7 Market News NUKKing 'em
12/18/2024 08:15 AM EST 24/7 Market News Cognition Therapeutics Reports Positive Phase 2 Study Results for CT1812 in Dementia with Lewy Bodies
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.